Denovamed

UK-based, early-stage biotech developing lipid metabolism-targeted small molecules for DR bacterial infections

placeHalifax, Nova Scotia, Canada calendar_todayFounded 2005 groups11 employees language denovamed.com

Innovation

5 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 118 times.

YearFilings
20141
20151
20161
20171
20193
20201
20212
20221
20233
20241
20252
20261

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon